Coeptis Therapeutics, Inc. Proceeds from Common Stock Issued
Coeptis Therapeutics, Inc. reported Proceeds from Common Stock Issued of $3.27 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2022-11-08
- Coeptis Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2022-09-30 was $1.32M, a 48.40% decline year-over-year.
- Coeptis Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2022-06-30 was $685.49K, a 52.76% decline year-over-year.
- Coeptis Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2022-03-31 was $1.27M, a 56.46% decline year-over-year.
- Coeptis Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2021-12-31 was $3.22M, a 671.14% increase year-over-year.
- Coeptis Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2021 was $10.14M, a 849.56% increase from fiscal 2020.
- Coeptis Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2020 was $1.07M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 4 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2022-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.01M derived: sum of 2 quarters · filed 2022-11-08 | $3.27M 10-Q · filed 2022-11-08 | $6.49M derived: sum of 4 quarters · filed 2022-11-08 | |
| 2022-06-30 | $685.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $1.95M 10-Q · filed 2022-08-02 | $5.17M derived: sum of 3 quarters · filed 2022-08-02 | $7.73M derived: sum of 4 quarters · filed 2022-11-08 | |
| 2022-03-31 | $1.27M 10-Q · filed 2022-05-12 | $4.49M derived: sum of 2 quarters · filed 2022-05-12 | $7.04M derived: sum of 3 quarters · filed 2022-11-08 | $8.49M derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-12-31 | $3.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $5.78M derived: sum of 2 quarters · filed 2022-11-08 | $7.23M derived: sum of 3 quarters · filed 2022-11-08 | $10.14M 10-K · filed 2022-03-11 | |
| 2021-09-30 | $2.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $4.01M derived: sum of 2 quarters · filed 2022-11-08 | $6.92M 10-Q · filed 2022-11-08 | $7.33M derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $4.36M 10-Q · filed 2022-08-02 | $4.78M derived: sum of 3 quarters · filed 2022-08-02 | $5.43M derived: sum of 4 quarters · filed 2022-08-02 | |
| 2021-03-31 | $2.91M 10-Q · filed 2022-05-12 | $3.32M derived: sum of 2 quarters · filed 2022-05-12 | $3.97M derived: sum of 3 quarters · filed 2022-05-12 | $3.97M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $417.50K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $1.07M derived: sum of 2 quarters · filed 2022-03-11 | $1.07M derived: sum of 3 quarters · filed 2022-03-11 | $1.07M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $650.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $650.00K derived: sum of 2 quarters · filed 2021-11-15 | $650.00K 10-Q · filed 2021-11-15 | ||
| 2020-08-31 | $0.00 10-Q/A · filed 2020-11-23 | ||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | |||
| 2020-03-31 | $0.00 10-Q/A · filed 2021-05-18 | ||||
| 2019-08-31 | $99.00 10-Q/A · filed 2020-11-23 |